Skip to main content
Maya Guglin, MD, Cardiology, Indianapolis, IN, Indiana University Health University Hospital

MayaEGuglinMD

Cardiology Indianapolis, IN

Adult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology

Director, Heart Failure and Transplant/Assist Devices, University of South Florida

Dr. Guglin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Guglin's full profile

Already have an account?

Education & Training

  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
  • Columbia Saint Luke's Medical Center
    Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1997 - 2000
  • The Volgograd State Medical University
    The Volgograd State Medical UniversityClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2000 - 2025
  • IN State Medical License
    IN State Medical License 2019 - 2025
  • KY State Medical License
    KY State Medical License 2014 - 2020
  • FL State Medical License
    FL State Medical License 2006 - 2015
  • MI State Medical License
    MI State Medical License 2003 - 2007
  • OH State Medical License
    OH State Medical License 1999 - 2005
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 509] Chemotherapy-Induced Cardiomyopathy: Anthracyclines and Trastuzumab Require Different Approach to Monitoring and Prevention
    Maya Guglin, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Noncompaction Cardiomyopathy: More than Just Trabeculations 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

  • Dobutamine Shortage: ACC Experts Offer Tips, Alternatives
    Dobutamine Shortage: ACC Experts Offer Tips, AlternativesAugust 11th, 2022
  • Feature | What You Need to Know: Guidance for Clinicians on Dobutamine Shortage
    Feature | What You Need to Know: Guidance for Clinicians on Dobutamine ShortageAugust 2nd, 2022
  • Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year
    Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 YearApril 4th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations